Join

Compare · CDAK vs CGC

CDAK vs CGC

Side-by-side comparison of Codiak BioSciences Inc. (CDAK) and Canopy Growth Corporation (CGC): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CDAK and CGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
  • CGC is the larger of the two at $2.86B, about 22.9x CDAK ($125.2M).
  • CGC has hit the wire 6 times in the past 4 weeks while CDAK has been quiet.
  • CGC has more recent analyst coverage (19 ratings vs 2 for CDAK).
MetricCDAKCGC
Company
Codiak BioSciences Inc.
Canopy Growth Corporation
Price
$0.06-53.11%
$1.03-3.27%
Market cap
$125.2M
$2.86B
1M return
-
-7.59%
1Y return
-
-20.08%
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NASDAQ
NYSE
IPO
2020
News (4w)
0
6
Recent ratings
2
19
CDAK

Codiak BioSciences Inc.

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12, an exosome therapeutic candidates, for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; exoASO-NLRP3 for multiple sclerosis, neuropathy, and neurodegeneration; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics, Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

CGC

Canopy Growth Corporation

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Latest CDAK

Latest CGC